NLRP3 and prostate carcinoma: Moreover, K+ efflux, one of the activation pathways of the NLRP3 inflammasome, has been identified as an early event in the apoptosis of prostate cancer cells (99), suggesting that the NLRP3 inflammasome may induce tumor cell apoptosis through this mechanism.